GlassScriptPhysician profile
Raimy Amasha
NPI 1760643498
$26,061.03
in general payments reported to CMS, 2019-2025
59 companies · $2,010 in 2025
The $2,010 reported for 2025 was more than what 82% of Pain Medicine (Anesthesiology) providers received nationally (typical 2025 total: $458).
See the full distribution for Pain Medicine (Anesthesiology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,835 · 2020: $4,557 · 2021: $6,328 · 2022: $3,323 · 2023: $2,836 · 2024: $2,172 · 2025: $2,010.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,890 · Education: $128.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,890.21 |
| Education | $127.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $8,469.69 | 2019-2025 | Proclaim, Eterna, Workmate Claris |
| Spinal Simplicity, LLC | $2,637.49 | 2021-2025 | Ha Minuteman G3-R |
| Lilly USA, LLC | $2,263.65 | 2019-2020 | |
| Nevro Corp. | $1,628.70 | 2019-2022 | |
| Boston Scientific Corporation | $1,188.96 | 2019-2025 | Intracept, Wavewriter Alpha Prime 16 |
| Abbvie INC. | $836.39 | 2019-2025 | Ubrelvy, Qulipta, Botox |
| Medinc of Texas | $764.00 | 2019 | |
| Collegium Pharmaceutical, INC. | $763.13 | 2019-2025 | Belbuca, Xtampza |
| Medtronic, INC. | $651.80 | 2022-2025 | Vanta Adaptivestim, Intellis Adaptivestim, Inceptiv |
| Pfizer INC. | $617.13 | 2019-2025 | |
| Si-Bone, INC. | $567.07 | 2021-2025 | |
| Vertiflex, INC. | $566.76 | 2019 | |
| Relievant Medsystems, INC. | $548.79 | 2021-2023 | Intracept |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $402.75 | 2021-2025 | Relistor, Trulance |
| Biohaven Pharmaceuticals, INC. | $356.14 | 2020-2021 |
Show all 59 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teva Pharmaceuticals USA, INC. | $274.88 | 2019-2021 | |
| Scilex Pharmaceuticals INC. | $274.44 | 2019-2024 | |
| Stimwave Technologies Incorporated | $265.10 | 2019-2020 | |
| Amgen INC. | $258.10 | 2019-2022 | |
| Arbor Pharmaceuticals, INC. | $246.48 | 2019-2022 | |
| Biodelivery Sciences International, INC. | $233.36 | 2019-2021 | |
| Medtronic USA, INC. | $191.95 | 2019-2020 | |
| Lundbeck LLC | $157.30 | 2024-2025 | Vyepti |
| Biohaven Pharmaceutical Holding Company LTD. | $149.97 | 2022 | |
| Bioventus LLC | $128.57 | 2023-2024 | Durolane, Gelsyn-3, Durolane |
| Novartis Pharmaceuticals Corporation | $124.37 | 2019-2021 | |
| Daiichi Sankyo INC. | $119.69 | 2019 | |
| Tersera Therapeutics LLC | $108.37 | 2021-2023 | Prialt |
| Allergan, INC. | $105.27 | 2020-2022 | |
| Almatica Pharma LLC | $89.17 | 2021-2022 | |
| Astrazeneca Pharmaceuticals LP | $80.58 | 2019 | |
| Redhill Biopharma INC. | $77.52 | 2020-2022 | |
| Painteq LLC | $76.83 | 2023-2024 | Painteq |
| Horizon Therapeutics Plc | $68.97 | 2019-2022 | |
| Vertical Pharmaceuticals, LLC | $57.25 | 2019 | |
| Spr Therapeutics, INC | $54.68 | 2019-2025 | Sprint Pns System |
| Zyla Life Sciences, INC. | $51.61 | 2019-2020 | |
| Forte Bio-Pharma LLC | $43.49 | 2021 | |
| Valinor Pharma, LLC | $41.63 | 2025 | Movantik |
| Zimmer Biomet Holdings, INC. | $41.45 | 2019-2024 | Gel-One Cross-Linked Hyaluronate |
| Nalu Medical, INC. | $40.23 | 2021 | |
| Depuy Synthes Sales INC. | $37.93 | 2020-2022 | |
| Azurity Pharmaceuticals, INC. | $36.53 | 2023-2024 | Horizant, Horizant |
| Curonix LLC | $34.85 | 2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Ibsa Pharma INC. | $34.25 | 2021-2023 | Tirosint, Licart |
| Averitas Pharma INC. | $32.42 | 2025 | Qutenza |
| Convatec INC. | $32.37 | 2024-2025 | |
| Mml US, INC. | $28.87 | 2023 | Reactiv8 |
| Kyowa Kirin, INC. | $23.92 | 2024 | Crysvita |
| Ultragenyx Pharmaceutical INC. | $23.58 | 2024 | Crysvita |
| Vertex Pharmaceuticals Incorporated | $22.54 | 2025 | |
| Baudax Bio INC. | $20.42 | 2020 | |
| Grt US Holding, INC. | $18.14 | 2021 | |
| Shionogi INC | $17.99 | 2019 | |
| Radius Health, INC. | $16.49 | 2021 | |
| Impel Pharmaceuticals INC. | $15.89 | 2023 | Trudhesa |
| Virtus Pharmaceuticals LLC | $15.19 | 2021 | |
| Assertio Therapeutics, INC. | $14.54 | 2020 | |
| Alnylam Pharmaceuticals INC. | $11.40 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Raimy Amasha listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.